Vedanta Biosciences

Vedanta Biosciences is a developer of immunotherapies aimed at treating immune-mediated and infectious diseases. The company's immunotherapy portfolio includes a proprietary suite of analyses for selecting pharmacologically potent strains, extensive proprietary datasets from human intervention studies, and rationally defined powdered consortia produced in cGMP-compliant facilities, enabling physicians to easily access live biotherapeutics for treating autoimmune and inflammatory diseases. Vedanta is advancing a new class of therapies that modulate the interaction pathways between the human microbiome and the host immune system.